MPM BioImpact’s Oncorus, Inc. ONCR Stock Holding History

MPM BioImpact’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,377,031	Closed	-$96.3K	–	38
2023 Q2	$96.3K	Hold	2,377,031	–	–	0.02%	34
2023 Q1	$818K	Hold	2,377,031	–	–	0.21%	29
2022 Q4	$601K	Hold	2,377,031	–	–	0.16%	30
2022 Q3	$2.02M	Hold	2,377,031	–	–	0.48%	33
2022 Q2	$3M	Hold	2,377,031	–	–	0.83%	27
2022 Q1	$4.23M	Hold	2,377,031	–	–	1.14%	24
2021 Q4	$12.5M	Hold	2,377,031	–	–	2.28%	11
2021 Q3	$22.2M	Hold	2,377,031	–	–	3.44%	8
2021 Q2	$32.8M	Hold	2,377,031	–	–	5.39%	7
2021 Q1	$33.1M	Hold	2,377,031	–	–	4.16%	7
2020 Q4	$76.8M	Buy	+2,377,031	New	+$55M	13.5%	4

Other funds holding ONCR

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

MPM BioImpact's ONCR Position: Q3 2023 in Review

MPM BioImpact sold out of Oncorus, Inc. (ONCR) in Q3 2023, closing a stake of 2,377,031 shares — an estimated $96.3K sold.

MPM BioImpact first reported a position in ONCR in Q4 2020 and held it in 11 quarters. The position peaked at $76.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds ONCR as of Q3 2023.

MPM BioImpact reported no remaining Oncorus, Inc. position as of Q3 2023 after selling out during the quarter.
MPM BioImpact sold 2,377,031 Oncorus, Inc. shares in Q3 2023, an estimated $96.3K.
MPM BioImpact first reported a position in Oncorus, Inc. in Q4 2020 and held it in 11 quarters.
MPM BioImpact's Oncorus, Inc. position peaked at $76.8M in Q4 2020.
1 fund tracked by Wall St. Rank held Oncorus, Inc. as of Q3 2023.

Based on MPM BioImpact's 13F filing for Q3 2023, filed 14 Nov 2023.